Standout Papers
Citation Impact
Citing Papers
Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation
2014 StandoutScienceNobel
Campylobacter gene polymorphism as a determinant of clinical features of Guillain–Barre syndrome
2005
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome
2010
Machine learning predicts new anti-CRISPR proteins
2020 StandoutNobel
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells
2016
PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex
2018 StandoutScienceNobel
The Genetic Bases for the Variation in the Lipo-oligosaccharide of the Mucosal Pathogen, Campylobacter jejuni
2002
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action
2019 StandoutNobel
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
Inhibition of CRISPR-Cas9 ribonucleoprotein complex assembly by anti-CRISPR AcrIIC2
2019 StandoutNobel
RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a
2017
Piezo1 in Smooth Muscle Cells Is Involved in Hypertension-Dependent Arterial Remodeling
2015
Ataxic Guillain-Barre syndrome and acute sensory ataxic neuropathy form a continuous spectrum
2011
Catalytically Active Cas9 Mediates Transcriptional Interference to Facilitate Bacterial Virulence
2019 StandoutNobel
No evidence of a link between influenza vaccines and Guillain–Barre syndrome–associated antiganglioside antibodies
2011
Guillain-Barré syndrome after exposure to influenza virus
2010
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
2014 Standout
Classification and evolution of type II CRISPR-Cas systems
2014 StandoutNobel
Anti-PMP22 antibodies in patients with inflammatory neuropathy
2000
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
1998 Standout
Selective Digestive Tract Decontamination Decreases Time on Ventilator in Guillain–Barré Syndrome
2011
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Plasma exchange for Guillain-Barré syndrome
2002
Continuous Spectrum of Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome
2007
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Guillain-Barré syndrome
2010
Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome
2003
Antibodies against ganglioside complexes in Guillain‐Barré syndrome and related disorders
2011
RNA-based recognition and targeting: sowing the seeds of specificity
2017 StandoutNobel
Antiganglioside antibodies are associated with axonal Guillain–Barré syndrome: A Japanese–Italian collaborative study
2011
Guillain-Barre Syndrome following Primary Cytomegalovirus Infection: A Prospective Cohort Study
2011
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
2016 StandoutNobel
CRISPR–Cas systems: beyond adaptive immunity
2014
New CRISPR–Cas systems from uncultivated microbes
2016 StandoutNatureNobel
The Influence of Ligand Valency on Aggregation Mechanisms for Inhibiting Bacterial Toxins
2008
Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
2007 Standout
Guillain–Barré Syndrome
2012 Standout
Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome
2005
Axonal conduction block at intermediate nerve segments in pure motor Guillain‐Barré syndrome
2011
Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes
2011
Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe
2011
An anti‐ganglioside antibody‐secreting hybridoma induces neuropathy in mice
2004
Siglecs at the Host–Pathogen Interface
2020
Early Electrodiagnostic Findings in Guillain-Barré Syndrome
2001
Antiganglioside antibodies in Guillain-Barre syndrome after a recent cytomegalovirus infection
1999
Localization of major gangliosides in the PNS: implications for immune neuropathies
2002
A decade of discovery: CRISPR functions and applications
2017
High-Resolution Transcriptome Maps Reveal Strain-Specific Regulatory Features of Multiple Campylobacter jejuni Isolates
2013
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy
2017 StandoutNatureNobel
Piezos thrive under pressure: mechanically activated ion channels in health and disease
2017 StandoutNobel
Overexpression of GD1a Ganglioside Sensitizes Motor Nerve Terminals to Anti-GD1a Antibody-Mediated Injury in a Model of Acute Motor Axonal Neuropathy
2005
Immunotherapy for Guillain-Barre syndrome: a systematic review
2007
Passive Transfer of IgG Anti-GM1 Antibodies Impairs Peripheral Nerve Repair
2010
A Broad-Spectrum Inhibitor of CRISPR-Cas9
2017 StandoutNobel
Conduction block in acute motor axonal neuropathy
2010
Programmable RNA recognition and cleavage by CRISPR/Cas9
2014 StandoutNatureNobel
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis
2004 Standout
Phase transitions in the assembly of multivalent signalling proteins
2012 StandoutNature
Comprehensive Analysis of Bacterial Risk Factors for the Development of Guillain‐Barré Syndrome afterCampylobacter jejuniEnteritis
2006
Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial
2004
Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens
2014
Involvement of sensory fibres in axonal subtypes of Guillain-Barre syndrome
2011
The CRISPR-Cas immune system: Biology, mechanisms and applications
2015
Is It Possible to Develop a “Universal” Influenza Virus Vaccine?
2017
Antibodies to gangliosides and galactocerebroside in patients with Guillain–Barré syndrome with preceding Campylobacter jejuni and other identical infections
1998
Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal
2001
Development and Applications of CRISPR-Cas9 for Genome Engineering
2014 Standout
Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies
2004
CRISPR–Cas systems exploit viral DNA injection to establish and maintain adaptive immunity
2017 Nature
Gut flora in health and disease
2003 Standout
Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy
2004
The role of the immune system in the generation of neuropathic pain
2012
Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice
2009 StandoutNobel
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
2016
Neurophysiological and immunohistochemical studies on Guillain-Barré syndrome with IgG anti-GalNAc-GD1a antibodies—effects on neuromuscular transmission
2004
Erythropoietin Enhances Nerve Repair in Anti-Ganglioside Antibody-Mediated Models of Immune Neuropathy
2011
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr� syndrome
1999
The roles of CRISPR–Cas systems in adaptive immunity and beyond
2015
A thermostable Cas9 with increased lifetime in human plasma
2017 StandoutNobel
The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice
2009
Vaccines and Guillain-Barré Syndrome
2009
Anti-GQ1b Ganglioside Antibody in Peripheral Nervous System Disorders
2004
Guillain-Barré syndrome
2007
Campylobacter jejuni acquire new host-derived CRISPR spacers when in association with bacteriophages harboring a CRISPR-like Cas4 protein
2015
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
2016 StandoutNobel
Synthesis and biological evaluation of 9-N-oxamyl sialosides as Siglec-7 ligands
2015
Peripheral neuropathies and anti-glycolipid antibodies
2002
I can see CRISPR now, even when phage are gone
2015
Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations
1999
Anti-Ganglioside Antibody-Mediated Activation of RhoA Induces Inhibition of Neurite Outgrowth
2011
Anti-ganglioside complex antibodies associated with severe disability in GBS
2006
Recovery patterns and long term prognosis for axonal Guillain-Barre syndrome
2005
Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation
2020 StandoutNobel
The Biology of CRISPR-Cas: Backward and Forward
2018 StandoutNobel
The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons
1997
Epidemiology of the Guillain-Barré syndrome
2001
Quantifying the Association between <i>Campylobacter</i> Infection and Guillain-Barré Syndrome: A Systematic Review
2010
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Cellular and genetic mechanisms of self tolerance and autoimmunity
2005 Nature
Increased Risk of Guillain‐Barré Syndrome following Recent Herpes Zoster: A Population‐Based Study across Taiwan
2010
Pathogenesis of Guillain–Barré syndrome
1999
The interplay between Siglecs and sialylated pathogens
2014
Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein
2017
Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barr� syndrome: A reappraisal
1999
Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity
2016
A CRISPR/Cas system mediates bacterial innate immune evasion and virulence
2013 Nature
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Guillain-Barré syndrome
2005 Standout
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding
2003
Axonal involvement at the common entrapment sites in Guillain-Barr� syndrome with IgG anti-GM1 antibody
1999
Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system
2004
Acute motor conduction block neuropathy Another Guillain–Barre syndrome variant
2003
GM1/GalNAc-GD1a complex
2008
Role of Envelopment in the HEV Life Cycle
2016
Campylobacter jejunifrom Patients with Guillain-Barre Syndrome Preferentially Expresses a GD1a-Like Epitope
2002
Differences in patterns of progression in demyelinating and axonal Guillain–Barre syndromes
2003
Patterns of Guillain-Barre syndrome in children
2007
The CRISPR-Associated Genecas2of Legionella pneumophila Is Required for Intracellular Infection of Amoebae
2013
Intravenous immunoglobulin for Guillain-Barré syndrome
2014
Prevention and Control of Seasonal Influenza with Vaccines
2016
AHaemophilus influenzaeStrain Associated with Fisher Syndrome Expresses a Novel Disialylated Ganglioside Mimic
2007
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 StandoutNobel
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
The new frontier of genome engineering with CRISPR-Cas9
2014 StandoutScienceNobel
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndrome
2004
Evolution and Ecology of CRISPR
2016
CRISPR-Cas: biology, mechanisms and relevance
2016 StandoutNobel
Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes
2015
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
CRISPR-CasΦ from huge phages is a hypercompact genome editor
2020 StandoutScienceNobel
CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9
2018
CRISPR-Cas Systems
2012
Binding of immunoglobulin G antibodies in Guillain–Barré syndrome sera to a mixture of GM1 and a phospholipid: Possible clinical implications
2003
Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain–Barre syndrome
1999
Immunolocalization of GQ1b and Related Gangliosides in Human Extraocular Neuromuscular Junctions and Muscle Spindles
2009
Antecedent infections in Fisher syndrome
2005
Global Epidemiology of Campylobacter Infection
2015 Standout
Nuclease Activity of Legionella pneumophila Cas2 Promotes Intracellular Infection of Amoebal Host Cells
2014
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation
2018 StandoutNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Acute motor axonal neuropathy after Mycoplasma infection
2004
Cas3 Protein—A Review of a Multi-Tasking Machine
2020
Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling
2020 StandoutNobel
Axonal Guillain-Barr� syndrome: Relation to anti-ganglioside antibodies andCampylobacter jejuni infection in Japan
2000
Mild forms of Guillain-Barre syndrome in an epidemiologic survey in the Netherlands
2000
Guillain–Barré syndrome, CIDP and other chronic immune‐mediated neuropathies
1998
Preceding infections, immune factors, and outcome in Guillain–Barre syndrome
2001
CRISPR-Cas guides the future of genetic engineering
2018 StandoutScienceNobel
Prognostic factors of Guillain-Barre syndrome after intravenous immunoglobulin or plasma exchange
1999
Miller Fisher syndrome and Haemophilus influenzae infection
2001
Intestinal flora in health and disease
1984
Early recognition of poor prognosis in Guillain-Barré syndrome
2011
GalNAc-GD1a in human peripheral nerve
2003
Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barre syndrome
2005
A Guillain-Barré syndrome variant with prominent facial diplegia
2009
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of Bart C. Jacobs being referenced
Guillain-Barré syndrome without sensory loss (acute motor neuropathy)
1995
Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain–Barré patients
2004
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
2008
Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain–Barré syndrome and Miller Fisher syndrome
2012
Guillain-Barré syndrome
2016 Standout
Guillain-Barre syndrome subtypes related to Campylobacter infection
2011
GM3, GM2 and GM1 mimics designed for biosensing: chemoenzymatic synthesis, target affinities and 900MHz NMR analysis
2008
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model
2008
Recurrent Guillain-Barre syndrome
2008
Anti–GM1 IgG antibodies induce leukocyte effector functions via Fcγ receptors
2003
Campylobacter jejuni lipopolysaccharides from Guillain–Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits
2000
Determination of pain and response to methylprednisolone in Guillain-Barré syndrome
2007
Genetic polymorphisms of macrophage-mediators in Guillain–Barré syndrome
2007
Cytomegalovirus infection and Guillain-Barre syndrome
1996
Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides
1997
Origin of ganglioside complex antibodies in Guillain–Barré syndrome
2007
Miller Fisher anti-GQ1b antibodies: ?-Latrotoxin-like effects on motor end plates
1999
Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome
1996
Detection and prevalence of α‐latrotoxin–like effects of serum from patients with Guillain–Barré syndrome
2002
A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain–Barré syndrome
2012
Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastro-enteritis and reactive arthritis
2009
Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome
1997
Filamin A mutation, a common cause for periventricular heterotopia, aneurysms and cardiac defects
2008
Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barr� syndrome
1997
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
2014
Cross-Reactive Antibodies against Gangliosides and Campylobacter jejuni Lipopolysaccharides in Patients with Guillaln-Barre or Miller Fisher Syndrome
1997
Hepatitis E virus and neurological injury
2015
Severity of Guillain–Barré syndrome is associated with Fcγ Receptor III polymorphisms
2005
Guillain–Barré syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity
2018
Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands
2001
Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain–Barré syndrome
2005
Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain–Barré syndrome
2002
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome
2004
Hepatitis E virus: Infection beyond the liver?
2016
Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barre syndrome.
1997
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain–Barre syndrome
2000
Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh
2010
Structure ofCampylobacter jejuniLipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barre and Miller Fisher Patients
2002
Enhanced, Sialoadhesin-Dependent Uptake of Guillain-Barré Syndrome-Associated Campylobacter jejuni Strains by Human Macrophages
2013
Tropical Sprue and Malnutrition in West Bengal
1970
Guillain-Barre Syndrome- and Miller Fisher Syndrome-Associated Campylobacter jejuni Lipopolysaccharides Induce Anti-GM 1 and Anti-GQ 1b Antibodies in Rabbits
2001
Molecular Characterization of Campylobacter jejuni from Patients with Guillain-Barre and Miller Fisher Syndromes
2000
Pain in Guillain-Barré syndrome
2010
Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy
2001
Rapidly progressive, predominantly motor Guillain-Barre syndrome with anti-GalNAc-GD1a antibodies
1999
Campylobacter jejuni Lipooligosaccharides Modulate Dendritic Cell-Mediated T Cell Polarization in a Sialic Acid Linkage-Dependent Manner
2011
The Guillain–Barré syndrome: a true case of molecular mimicry
2003
The spectrum of antecedent infections in Guillain-Barre syndrome
1998
Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
2000
Structural Characterization of Campylobacter jejuni Lipooligosaccharide Outer Cores Associated with Guillain-Barre and Miller Fisher Syndromes
2007
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome
2004
Clinical features and response to treatment in Guillain-Barr� syndrome associated with antibodies to GM1b ganglioside
2000
HLA class II alleles are not a general susceptibility factor in Guillain–Barre syndrome
2005
Prediction of respiratory insufficiency in Guillain‐Barré syndrome
2010
Gastroenteritis-associated Guillain–Barre syndrome on the Caribbean Island Curacao
2001